Cargando…

Explosive Disease Progression After Single-Agent B-cell Maturation Antigen-Targeted Treatment in Multiple Myeloma: A Report of Three Cases in Sheikh Shakhbout Medical City

Patients with “penta-refractory” multiple myeloma (MM) are challenging to treat given the limited treatment options available to them. Belantamab mafodotin is the first B-cell maturation antigen (BCMA)-targeting antibody-drug conjugate approved for the treatment of relapsed/refractory MM (RRMM). In...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jaber, Waed, Abdaljalil, Ammar, Ali, Aya, Abu Haleeqa, Mohamed, Mheidly, Kayane
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10544041/ https://www.ncbi.nlm.nih.gov/pubmed/37791224 http://dx.doi.org/10.7759/cureus.44433

Ejemplares similares

Knowledge and practice and attitude toward cupping therapy among physicians in Sheikh Khalifa medical city
por: Al Zaabi, Meera, et al.
Publicado: (2023)

Prevalence and Management of Metabolic Syndrome in Adult Psychiatric Patients Receiving Second-Generation Antipsychotics at Sheikh Khalifa Medical City
por: Mohammed, Wadha, et al.
Publicado: (2022)

Predictors of protein losing enteropathy after Fontan completion: An 8-year retrospective study at Sheikh Khalifa Medical City
por: AbdelMassih, Antoine Fakhry, et al.
Publicado: (2023)

Allergic Conjunctivitis at Sheikh Zayed Regional Eye Care Center, Gambia
por: Wade, Patricia D, et al.
Publicado: (2012)

Knowledge of Nurses in Prevention of Hospital Infection in Hospital “Sheikh Zayed” Vushtrri
por: Mustafa, Mexhit, et al.
Publicado: (2019)

Genetic Relationship between Salmonella Isolates Recovered from Calves and Broilers Chickens in Kafr El-Sheikh City Using ERIC PCR
por: Tawfik, Rasha Gomaa, et al.
Publicado: (2022)

Evaluation of Nosocomial Infection in Patients at hematology-oncology ward of Dr. Sheikh children’s hospital
por: Ghassemi, A, et al.
Publicado: (2015)

Wadi el-Sheikh: A new archaeological investigation of ancient Egyptian chert mines
por: Köhler, E. Christiana, et al.
Publicado: (2017)

Prevalence of Depression and Anxiety among Patients with Multiple Sclerosis Attending the MS Clinic at Sheikh Khalifa Medical City, UAE: Cross-Sectional Study
por: Alsaadi, Taoufik, et al.
Publicado: (2015)

Remdesivir Use in Low Weight, Premature, and Renally Impaired Infants With SARS-CoV-2 Infection in Sheikh Khalifa Medical City, UAE: Case Series
por: Mohammed, Wadha, et al.
Publicado: (2023)

Ruminant Brucellosis in the Kafr El Sheikh Governorate of the Nile Delta, Egypt: Prevalence of a Neglected Zoonosis
por: Hegazy, Yamen M., et al.
Publicado: (2011)

Scabies among primary schoolchildren in Egypt: sociomedical environmental study in Kafr El-Sheikh administrative area
por: Hegab, Doaa Salah, et al.
Publicado: (2015)

Impact of the relative dose intensity on survival of patients with high‐risk myelodysplastic syndromes treated with Azacitidine
por: Laribi, Kamel, et al.
Publicado: (2019)

Immunotherapeutic strategies targeting B cell maturation antigen in multiple myeloma
por: Fang, Yi, et al.
Publicado: (2021)

TnT: T Antigen and Telomerase, an Explosive Route to Cancer
por: Ray, F. Andrew
Publicado: (2008)

Optimizing Supportive Care in COVID-19 Patients: A Multidisciplinary Approach
por: Abu Haleeqa, Mohamed, et al.
Publicado: (2020)

Risk of infections with B-cell maturation antigen-directed immunotherapy in multiple myeloma
por: Mohan, Meera, et al.
Publicado: (2022)

Role of Anti-B-Cell Maturation Antigen (BCMA) in the Management of Multiple Myeloma
por: Rinaldi, Ikhwan, et al.
Publicado: (2022)

Targeting B Cell Maturation Antigen in Patients with Multiple Myeloma: Current Perspectives
por: Shrivastava, Trilok, et al.
Publicado: (2023)

Soluble B-cell maturation antigen as a monitoring marker for multiple myeloma
por: Wiedemann, Ádám, et al.
Publicado: (2023)

Chimeric antigen receptor T cell targeting B cell maturation antigen immunotherapy is promising for multiple myeloma
por: Ma, Tiantian, et al.
Publicado: (2019)

Chimeric Antigen Receptor-Modified T Cell Therapy in Multiple Myeloma: Beyond B Cell Maturation Antigen
por: Timmers, Marijke, et al.
Publicado: (2019)

Recombinant immunotoxins targeting B-cell maturation antigen are cytotoxic to myeloma cell lines and myeloma cells from patients
por: Bera, T K, et al.
Publicado: (2018)

Dr. Naeem Toosy, MBChB, MSc, FRCS (Ed), FRCEM; Consultant and Acting Head of Department of Emergency Medicine at Sheikh Khalifa General Hospital
Publicado: (2018)

Sulfur as a binding agent of aggregates in explosive eruptions
por: Scolamacchia, Teresa, et al.
Publicado: (2014)

Preclinical development of a humanized chimeric antigen receptor against B-cell maturation antigen for multiple myeloma
por: Perez-Amill, Lorena, et al.
Publicado: (2020)

B-cell maturation antigen (BCMA) in multiple myeloma: the new frontier of targeted therapies
por: Sanchez, Larysa, et al.
Publicado: (2021)

B-cell maturation antigen targeting strategies in multiple myeloma treatment, advantages and disadvantages
por: Nobari, Shirin Teymouri, et al.
Publicado: (2022)

CAR-T-Cell Therapy in Multiple Myeloma: B-Cell Maturation Antigen (BCMA) and Beyond
por: Mishra, Abhinava K., et al.
Publicado: (2023)

Nanoparticles in explosives detection – the state-of-the-art and future directions
por: Peveler, William J., et al.
Publicado: (2017)

B-cell maturation antigen (BCMA) in multiple myeloma: rationale for targeting and current therapeutic approaches
por: Shah, Nina, et al.
Publicado: (2020)

The exploration of B cell maturation antigen expression in plasma cell dyscrasias beyond multiple myeloma
por: Xu, Yanjie, et al.
Publicado: (2023)

PB2104: SOLUBLE B-CELL MATURATION ANTIGEN AS A MONITORING MARKER FOR MULTIPLE MYELOMA
por: Wiedemann, Ádám, et al.
Publicado: (2023)

Ureteral injuries from gunshots and shells of explosive devices
por: Abid, Ammar Fadil, et al.
Publicado: (2010)

Explosives
por: Meyer, Rudolf
Publicado: (1977)

Targeting B Cell Maturation Antigen (BCMA) in Multiple Myeloma: Potential Uses of BCMA-Based Immunotherapy
por: Cho, Shih-Feng, et al.
Publicado: (2018)

Serum B-cell maturation antigen: a novel biomarker to predict outcomes for multiple myeloma patients
por: Ghermezi, Michael, et al.
Publicado: (2017)

Targeting B-cell maturation antigen increases sensitivity of multiple myeloma cells to MCL-1 inhibition
por: Cuenca, Marta, et al.
Publicado: (2021)

Mass spectrometry-based identification of a B-cell maturation antigen-derived T-cell epitope for antigen-specific immunotherapy of multiple myeloma
por: Bilich, Tatjana, et al.
Publicado: (2020)

Interpol review of the analysis and detection of explosives and explosives residues
por: Klapec, Douglas J., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ljgrfjcsdf3us1q2vhqa4slf5h